FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 100 | -60.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 250 | -80.0% | 0.00% | – |
| Q3 2017 | $4,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | +25.0% | 1,250 | -28.6% | 0.00% | – |
| Q4 2016 | $4,000 | -60.0% | 1,750 | -46.2% | 0.00% | – |
| Q3 2016 | $10,000 | -23.1% | 3,250 | -58.1% | 0.00% | – |
| Q2 2016 | $13,000 | +85.7% | 7,750 | +93.8% | 0.00% | – |
| Q1 2016 | $7,000 | +133.3% | 4,000 | +300.0% | 0.00% | – |
| Q4 2015 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | +33.3% | 1,000 | +42.9% | 0.00% | – |
| Q4 2014 | $3,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |